000 01281 a2200265 4500
005 20250517123426.0
264 0 _c20180301
008 201803s 0 0 eng d
022 _a1873-2496
024 7 _a10.1016/j.urolonc.2016.02.006
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aLin, Daniel
245 0 0 _aCommentary on "RNA biomarkers associated with metastatic progression in prostate cancer: A multi-institutional high-throughput analysis of SChLAP1." Prensner JR, Zhao S, Erho N, Schipper M, Iyer MK, Dhanasekaran SM, Magi-Galluzzi C, Mehra R, Sahu A, Siddiqui J, Davicioni E, Den RB, Dicker AP, Karnes RJ, Wei JT, Klein EA, Jenkins RB, Chinnaiyan AM, Feng FY, University of Washington-Urology, Seattle, WA. Lancet Oncol 2014; 15(13):1469-80.
_h[electronic resource]
260 _bUrologic oncology
_c11 2016
300 _a521-522 p.
_bdigital
500 _aPublication Type: Journal Article; Comment
650 0 4 _aBiomarkers
650 0 4 _aDisease Progression
650 0 4 _aHumans
650 0 4 _aMale
650 0 4 _aProstatic Neoplasms
_xgenetics
650 0 4 _aRNA, Long Noncoding
_xgenetics
773 0 _tUrologic oncology
_gvol. 34
_gno. 11
_gp. 521-522
856 4 0 _uhttps://doi.org/10.1016/j.urolonc.2016.02.006
_zAvailable from publisher's website
999 _c26578362
_d26578362